Alaunos Therapeutics | ZIOP - Debt


Alaunos Therapeutics reported $10.99M in Debt for its fiscal quarter ending in March of 2023.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Amgen USD 57.32B 2.72B Mar/2026
AstraZeneca USD 32.24B 1.68B Jun/2026
Baxter International USD 9.69B 93M Mar/2026
Biogen USD 8.09B 1.53B Jun/2026
Bioline Rx USD 9.07M 2.31M Mar/2026
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Celltrion KRW 160.58B 733.3M Mar/2026
Corcept Therapeutics USD 9.64M 3.53M Mar/2026
Cspc Pharmaceutical CNY 641.11M 146.11M Dec/2025
Curis USD 0 0 Jun/2022
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Divis Laboratories Ltd INR 70M 30M Mar/2026
Gilead Sciences USD 22.17B 2.76B Mar/2026
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Incyte USD 38.27M 1.16M Jun/2026
Intrexon USD 0 13.82M Jun/2024
Ionis Pharmaceuticals USD 1.91B 425.5M Jun/2026
J&J USD 54.99B 7.05B Mar/2026
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Merck USD 49.12B 222M Mar/2026
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Novartis USD 49.01B 2.02B Jun/2026
Organigram Holdings CAD 8.2M 554K Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 63.73B 231M Mar/2026
Pharma Mar EUR 45.84M 1.7M Jun/2026
PTC Therapeutics USD 286.94M 2.42B Mar/2026
Qiagen NV USD 1.65B 165.82M Mar/2026
Regeneron Pharmaceuticals USD 2.71B 400K Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sartorius EUR 4.05B 248.8M Jun/2026
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
TG Therapeutics USD 753.56M 499.85M Mar/2026
Tilray USD 640.95M 35.17M Jun/2022
Verastem USD 66.79M 26.7M Sep/2024
Zealand Pharma A/S 414M 8.23M Mar/2026
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026